Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment
Primary Purpose
Knee Osteoarthritis, Chondropathy
Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint
Sponsored by
About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring MSC, SVF, adipose tissue, knee osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Adults with symptomatic gonarthrosis diagnosed based on the X-ray, MRI and clinical examination, previously unsuccessfully treated (rehabilitation, NSAIDs, hyaluronic acid, platelet-rich plasma)
- Primary knee osteoarthritis
- Willingness and consent to participate in the study
- Readiness to attend control visits
Exclusion Criteria:
- Failure to meet the inclusion criteria
- Active chronic infection
- Metal implant made of a ferromagnetic material that will exclude the patient from magnetic resonance imaging
- Use of anticoagulants
- General and intra-articular use of steroids during the last year
- Pregnancy, breastfeeding
- Any autoimmune and rheumatic disease, or conditions that influence the accuracy of test results
- Taking drugs or cytostatic medications in the last 30 days
- Mental disorders, alcohol and drug addiction
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Enzymatic digestion group
Mechanical fragmentation group
Arm Description
A group treated with a stromal vascular fraction (SVF) with mesenchymal stromal cells (MSC) injection in the knee joint after an enzymatic digestion of autologous adipose tissue
A group treated with a mechanically fragmented (using Lipogems device) autologous adipose tissue injection in the knee joint
Outcomes
Primary Outcome Measures
Changes in patients reported outcome measures - Knee Injury and Osteoarthritis Outcome Score (KOOS)
The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included.
Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.
Changes in flexibility of the knee joint
Range of motion assessment by goniometer measurements
Secondary Outcome Measures
Changes in X-ray imaging of the knee joint in a standing position (AP view)
Articular cartilage volume evaluation by joint gap measurements
Changes in MRI with T-2 Mapping of the knee cartilage
Articular cartilage quality evaluation in T-2 Mapping
Full Information
NCT ID
NCT04675359
First Posted
December 14, 2020
Last Updated
January 7, 2021
Sponsor
Medical University of Warsaw
1. Study Identification
Unique Protocol Identification Number
NCT04675359
Brief Title
Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment
Official Title
Comparison of the Treatment Results of Knee Osteoarthritis Using Adipose Tissue Mesenchymal Stromal Cells Derived Through Enzymatic Digestion and Mechanically Fragmented Adipose Tissue
Study Type
Interventional
2. Study Status
Record Verification Date
December 2020
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2021 (Anticipated)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of Warsaw
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to compare the clinical effects of treatment of knee osteoarthritis using adipose tissue mesenchymal stromal cells obtained by an enzymatic method with the outcomes of the therapy with the mechanically fragmented adipose tissue. Identification and functional analysis of the regenerative capacity of MSCs derived from the adipose tissue depending on three variables (body weight, sex and age) will help to develop a targeted therapy for different groups of patients and will determine the effectiveness of both methods of treatment. An attempt was made to identify the groups of patients with the greatest regeneration potential of the adipose tissue, and thus indicate those with the most probable improvement of the joint condition.
Detailed Description
Based on the calculation of the sample size using power analysis of the test, investigators plan to include 100 adults with primary knee osteoarthritis in this study. The patients will undergo lipoaspiration under sterile conditions of the operating theatre, the collected lipoaspirates will be further processed - enzymatically with the use of collagenase or mechanically using the Lipogems system. After collection, lipoaspirates will be immediately transferred to the laboratory of the Department of Regenerative Medicine with a tissue and cells bank in Warsaw, and the preparations will be administered to the patients' knee joints in the operating room under ultrasound control.
The Lipogems system is defined as a minimal tissue manipulation system. In contrast, the administration of preparations produced using an enzymatic method requires advanced actions.
Lipoaspiration will be performed using blind cannulas and vacuum syringes introduced through the abdominal wall with a three-millimetre incision on the skin after previous injection to the adipose tissue with modified Klein's solution (500 ml of saline solution, 1 ml of adrenaline, 40 ml of 2% lignocaine), which makes the collection easier. 10 ml of the collected adipose tissue will be used to examine the samples after previous gradient drainage from Klein's solution. Immediately after collection, the samples will be sent to the laboratory for analysis (cell count testing, culture, phenotype identification, analysis by flow cytometry).
The patients will be monitored in the hospital outpatient clinic for one year after the procedure; the control visits will take place: after 2 and 6 weeks, then after 3 and 6 months and after a year. A physical examination and the assessment using the KOOS questionnaire will be performed. Before the procedure and after one year, an X-ray and MRI with T-2 Mapping will be carried out in order to evaluate the condition of the cartilage.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis, Chondropathy
Keywords
MSC, SVF, adipose tissue, knee osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Enzymatic digestion group
Arm Type
Active Comparator
Arm Description
A group treated with a stromal vascular fraction (SVF) with mesenchymal stromal cells (MSC) injection in the knee joint after an enzymatic digestion of autologous adipose tissue
Arm Title
Mechanical fragmentation group
Arm Type
Active Comparator
Arm Description
A group treated with a mechanically fragmented (using Lipogems device) autologous adipose tissue injection in the knee joint
Intervention Type
Procedure
Intervention Name(s)
Autologous adipose derived Mesenchymal Stromal Cells (MSC) injection into the knee joint
Other Intervention Name(s)
Autologous mechanically fragmented adipose tissue injection into the knee joint using Lipogems device
Intervention Description
Injections of the two adipose tissue derived products containing MSCs into the knee joints with osteoarthritis
Primary Outcome Measure Information:
Title
Changes in patients reported outcome measures - Knee Injury and Osteoarthritis Outcome Score (KOOS)
Description
The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included.
Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved.
Time Frame
1,3,6 and 12 months after procedure
Title
Changes in flexibility of the knee joint
Description
Range of motion assessment by goniometer measurements
Time Frame
1,3,6, and 12 months after procedure
Secondary Outcome Measure Information:
Title
Changes in X-ray imaging of the knee joint in a standing position (AP view)
Description
Articular cartilage volume evaluation by joint gap measurements
Time Frame
6 months and 1 year after procedure
Title
Changes in MRI with T-2 Mapping of the knee cartilage
Description
Articular cartilage quality evaluation in T-2 Mapping
Time Frame
6 months and 1 year after procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults with symptomatic gonarthrosis diagnosed based on the X-ray, MRI and clinical examination, previously unsuccessfully treated (rehabilitation, NSAIDs, hyaluronic acid, platelet-rich plasma)
Primary knee osteoarthritis
Willingness and consent to participate in the study
Readiness to attend control visits
Exclusion Criteria:
Failure to meet the inclusion criteria
Active chronic infection
Metal implant made of a ferromagnetic material that will exclude the patient from magnetic resonance imaging
Use of anticoagulants
General and intra-articular use of steroids during the last year
Pregnancy, breastfeeding
Any autoimmune and rheumatic disease, or conditions that influence the accuracy of test results
Taking drugs or cytostatic medications in the last 30 days
Mental disorders, alcohol and drug addiction
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Krześniak, MD
Phone
+48600104793
Email
anna.krzesniak@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Artur Stolarczyk, MD, PhD
Email
drstolarczyk@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Artur Stolarczyk, MD, PhD
Organizational Affiliation
Medical University of Warsaw
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33655941
Citation
Krzesniak AM, Radzimowski K, Stolarczyk A. Comparison of the treatment results of knee osteoarthritis using adipose tissue mesenchymal stromal cells derived through enzymatic digestion and mechanically fragmented adipose tissue. Medicine (Baltimore). 2021 Mar 5;100(9):e24777. doi: 10.1097/MD.0000000000024777.
Results Reference
derived
Learn more about this trial
Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment
We'll reach out to this number within 24 hrs